ARTICLE | Distillery Therapeutics
Ophthalmic disease
September 26, 2017 8:11 PM UTC
Mouse studies suggest a cell-permeable CAV1-based fusion peptide could help treat CNV and retinal neovascularization. In choroid and retina samples from a mouse model of CNV, levels of CAV1 were highe...